Holly B. Kordasiewicz, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 362 shares at $84.30 ($31K) on 2026-07-07, disclosed to the SEC on 2026-07-09.
Scheduled sale ($31k) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |